PSA Test Helps Low-Risk Patients Avoid Surgery and Radiation

Prolaris is a prostate-specific antigen (PSA) genetic test that analyzes cancer cells of patients diagnosed with prostate cancer. The test determines the aggressiveness of the cancer, helping physicians identify low- and medium-risk patients.

This testing enables doctors to actively monitor a patient's cancer and choose less aggressive forms of treatment for less advanced cases, ultimately helping some patients avoid unnecessary surgery or radiation.

For more videos, visit our partners at The Doctor's Channel.